A Study Measuring The Impact Of A Proteomic Assay In Distinguishing Bipolar I Disorder, Bipolar II Disorder, And Major Depressive Disorder In People Who Are Currently Depressed
Posted Date: Feb 24, 2016
- Investigator: Susan Lynn Mcelroy
- Specialties: Psychiatry/Psychology, Bipolar Disorder
- Type of Study: Observational/Survey
The Lindner Center of HOPE is conducting a research study that will evaluate people in a current depressive episode. Participants will be treated under the direction of their doctor and provide 3 blood samples during the study. The purpose of the study is to examine if unipolar depression, bipolar I or bipolar II depression can be determined from a blood sample. The study will last 9 weeks (6 visits during that time). Participants will receive treatment from their regular doctor and not from the study.
Criteria:
Adults 18 To 70 Who Have Been Diagnosed With Major Depression, Bipolar Type I Or Bipolar Type Ii Disorder And Currently Depressed May Be Eligible To Participate.
Keywords:
Mania, Mood Change, Bipolar Disorder, Psychiatry , Manic Depression
For More Information:
Brian Martens
(513) 536-0707
brian.martens@lindnercenter.org